Form 4 · Filed Jul 20, 2026, 08:10 PM UTC
HRTX/HERON THERAPEUTICS, INC. /DE/
Forbes William P — EVP, Chief Development Officer
AI Thesis
A thesis has not been generated for this filing yet — usually available within 60 seconds of EDGAR publication. Refresh shortly.
Research signal, not investment advice. Form 4 AI surfaces SEC filings and applies an analytical layer — it does not predict prices or recommend trades. Past performance does not guarantee future results. See methodology and public track record for how scores are computed.
Transactions
3 rows| Date | Code | Direction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Jul 19, 2026 | M | other | 3,874 | — | — | 225,485 |
| Jul 19, 2026 | F | other | 1,101 | $0 | $517 | 224,384 |
| Jul 19, 2026 | M | other | 3,874 | — | — | 23,246 |
Source: SEC EDGAR raw filing ↗ · Accession 0001193125-26-308922